tiprankstipranks
pc:kenai

Kenai Therapeutics

Kenai Therapeutics is a clinical-stage biotechnology company pioneering next-generation approaches to cure neurological conditions. The company develops off-the-shelf, allogeneic neuron replacement and gene-modified cell therapies, including RNDP-001 for idiopathic Parkinson's disease, and partners with FUJIFILM Cellular Dynamics for scalable, cryopreserved manufacturing.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$8M
Total Amount Raised$8M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$8M
Latest Funding Amount$8M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 05, 2026
Investment
$8.00M

Investors

Investor Name
Funding Round

Related News and Analysis